Investment Outlook 2020 Late cycle rebound

We are at a late cycle inflection point. But late cycle does not mean end cycle. Are short-term recession fears overdone?

02 Dec 2019

Rather, we expect a moderate growth reacceleration in early 2020 as geopolitical risks abate, China's growth slowdown stabilizes and as the lagged impact of looser monetary policy globally feeds through to demand. Lower USD borrowing costs also herald an important easing of financial conditions to emerging markets that is likely to be positive for global demand growth.

Investment outlook 2020 – global manufacturing indicators turning

The global demand slowdown in 2019 has been largely driven by global industrial production and trade as the negative impacts of the US/China trade dispute have increased.

But global manufacturing lead indicators are now turning and we expect these tentative signs of improvement to become more definitive in the coming months.

Lead indicators suggest global manufacturing growth is rebounding

Source: UBS Asset Management, Refinitv, as of November 2019.

Easing of financial conditions key

Key to the moderate demand pickup we expect is the delayed boost to economic activity from the significant easing of global financial conditions.

Over the past year, the US Federal Reserve has performed a sharp policy pivot from the tighter stance and rhetoric of late 2018 to its current more accommodative position. Recent statements support our view that the Fed is now more likely to let US growth and inflation 'run hot' than it is to tighten policy early and risk a sharp downturn.

We do not see the US Federal Funds rate rising in the near term. Importantly, the shift to looser policy has not taken place only in the US, but has been broad based across both developed and emerging markets.

Absent any extraneous demand shock, we see this supporting growth throughout the early part of 2020 as the boost from lower rates feeds through more powerfully to manufacturing. We also expect consumption growth to remain resilient in 2020, underpinned by low unemployment and solid wage growth. Should growth falter, we believe that calls for fiscal stimulus to play a greater role in the overall policy mix will grow louder in a number of major economies.

Subscribe now

Perspectives matter. Tune in to our insights.

China's policy stance

Despite GDP at its lowest level since 1992, the one major central bank whose policy stance has not moved to unequivocally loose is the People's Bank of China (PBoC).

The five basis point cut in one-year bank lending rates in early November is evidence that the PBoC is not ignoring the growth slowdown. But its modest nature perfectly reflects the difficult balancing act it faces between conflicting cyclical and structural goals. This does not concern us unduly.

With the full monetary and fiscal policy toolkit at their disposal the Chinese authorities are able to turn to other measures alongside interest rates to influence the rate of demand while rebalancing its drivers.

We expect Chinese growth to stabilize as these policy actions take effect and there is scope for further stimulus measures if necessary.

Geopolitics a risk and opportunity

Geopolitics represent both risk and opportunity. Brexit and the US/China trade standoff were the headline geopolitical stories of 2019. However, the probability of a worst case scenario on both issues has clearly diminished. We see sufficient goodwill in the most recent US/China rhetoric to suggest that some of the previously announced tariffs could be cancelled rather than just postponed. Such an outturn could provide much needed support to global corporate confidence.

Short-term recession concerns overdone

Twelve months ago we said that global growth fears were overdone given the likely resilience of developed world labor markets. We therefore entered 2019 with a positive view on global equities that has since been well rewarded.

We continue to see short-term recession concerns as exaggerated and there are major opportunities from a tactical asset allocation perspective in an extension of the business cycle and a stabilization of growth prospects relative to what is priced into markets. We expect some sharp rotation within risk assets.

Investment outlook 2020 - Favour growth sensitive equity markets

Given our belief in a modest demand rebound, we currently favor the more growth sensitive equity markets of the eurozone, China, Japan and emerging markets. US equities have enjoyed a sustained period of outperformance in a global context. We understand the tactical argument that the more domestically focused US indices are less exposed to near term trade war concerns. However, as 2020 progresses we see a mix of both cyclical and structural factors coming into play. In particular headlines around the US presidential election and potentially dramatic changes in US economic policy will likely prompt bouts of volatility that may disadvantage US equities over their international peers. Still, investors must weigh the probabilities of one candidate having the full legislative backing to generate truly transformational change.

Strong argument for China / EM equities

There is scope for Chinese equities to rerate higher as capital markets open up to international investors and we see capital flows increasing in the wake of the inclusion of onshore Chinese equities in MSCI's widely followed emerging market (EM) equity indices. There are also strong arguments for wider EM equities, which we see as the major beneficiary of a global demand bounce, any US/China trade truce and of the cut in USD borrowing costs.

Yield curves steepening

A modest rebound in global demand suggests to us that there will be at least some upward pressure on longer-dated government bond yields given the very low growth and inflation assumptions reflected in the 10yr government bond prices of developed countries including Japan, Germany and Switzerland. With monetary policy likely to remain loose even in the face of improving data, we see developed world nominal yield curves steepening.

Chinese bonds stand out

Our favored market for this view is the US, where we are long the UST two year and short the UST 10 year in a yield curve 'steepener' to exploit this scenario. Given relatively high nominal and real yields Chinese bonds stand out to us as the one genuinely attractive major sovereign bond market. Inclusion in major bond indices is likely to see additional structural downward pressure on Chinese yields.

Credit also offers some compelling opportunities to play a cyclical uptick. As with EM equities, we see a rebound in global manufacturing and lower USD funding costs as being supportive for emerging market credit in general. Against this backdrop, both local and hard currency EM yield spreads over US Treasuries appear attractive vs. US investment grade and US high yield.

Staying flexible and nimble to exploit asset allocation opportunities in 2020 and beyond

The maturity of the cycle, residual geopolitical risks and some crowded positions across asset classes raise the prospect of intermittent bouts of headline and intra-market volatility in 2020. In a lower growth environment, returns from risk assets are also likely to be lower than investors have enjoyed for most of the last decade. Given this backdrop, we believe that staying flexible and nimble to exploit asset allocation opportunities as and when they arise will be important in 2020 and beyond.

What surprises await investors in 2020?

How can you prepare your portfolios if unexpected events happen in 2020?

Evan Brown

Head of Multi-Asset Strategy

Evan drives macro research and tactical asset allocation investment process across asset classes. Additionally, he drives thought leadership to clients through advisory mandates and investment publications.

Prior to joining Investment Solutions, Evan was a strategist and trader for macro hedge fund portfolios at UBS O'Connor and Millennium.

Previously, Evan co-ran US FX Strategy at Morgan Stanley, where he ranked 2nd in the All-Americas Institutional Investor poll for Currencies/Foreign Exchange.

Evan worked on the New York Fed's Open Markets Desk from 2006 to 2009, where he briefed senior policymakers on financial market developments and helped build policy responses during the Great Financial Crisis.

Singapore Retail Investors

PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE PROCEEDING. BY UTILIZING THE WEBSITE AND PAGES THEREOF LOCATED AT WWW.UBS.COM/AM-SG ("WEBSITE"), YOU ACKNOWLEDGE THAT YOU HAVE READ THESE TERMS AS WELL AS THE GLOBAL TERMS OF USE (collectively "TERMS") AND THAT YOU AGREE TO BE BOUND BY THEM. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, YOU ARE NOT AN AUTHORIZED USER OF THESE SERVICES AND YOU SHOULD NOT USE THIS WEBSITE.

This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2020 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Reset